<code id='D8CBB8E357'></code><style id='D8CBB8E357'></style>
    • <acronym id='D8CBB8E357'></acronym>
      <center id='D8CBB8E357'><center id='D8CBB8E357'><tfoot id='D8CBB8E357'></tfoot></center><abbr id='D8CBB8E357'><dir id='D8CBB8E357'><tfoot id='D8CBB8E357'></tfoot><noframes id='D8CBB8E357'>

    • <optgroup id='D8CBB8E357'><strike id='D8CBB8E357'><sup id='D8CBB8E357'></sup></strike><code id='D8CBB8E357'></code></optgroup>
        1. <b id='D8CBB8E357'><label id='D8CBB8E357'><select id='D8CBB8E357'><dt id='D8CBB8E357'><span id='D8CBB8E357'></span></dt></select></label></b><u id='D8CBB8E357'></u>
          <i id='D8CBB8E357'><strike id='D8CBB8E357'><tt id='D8CBB8E357'><pre id='D8CBB8E357'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:96
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Pharma’s losing bet in New Jersey
          Pharma’s losing bet in New Jersey

          PfizerCEOAlbertBourlawasoneofafewpharmaceuticalexecutiveswhodonatedtoafailedSenatecampaigninNewJerse

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,